The role of HLA antibodies in allogeneic SCT: is the ‘type-and-screen’ strategy necessary not only for blood type but also for HLA?
- 9 January 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 47 (12), 1499-1506
- https://doi.org/10.1038/bmt.2011.249
Abstract
The role of HLA antibodies in SCT has drawn increasing attention because of the significantly increased number of patients who receive HLA-mismatched SCT, including cord blood transplantation, haploidentical SCT and unrelated SCT. Technical advancements in the methods of HLA Ab testing have realized rapid, accurate and objective identification, as well as quantification of specific HLA antibodies. Recent clinical studies have suggested that the presence of donor-specific HLA antibodies (DSA) in patients is associated with graft failure in HLA-mismatched SCT when the above-listed stem cell sources are used and results in different impacts. Of note, most of the ‘HLA-matched’ unrelated SCT actually involve HLA mismatches in HLA-DP and the presence of antibodies against this locus has been reported to be associated with graft failure. Thus, HLA Ab should be examined as a work-up for all patients who undergo SCT from ‘alternative donors.’ The simplest route for preventing HLA Ab-mediated graft failure in Ab-positive patients is to avoid donors who possess the target Ag of HLA antibodies. If SCT from such donors must be performed, treatment for DSA before SCT may improve the chances of successful donor engraftment.Keywords
This publication has 66 references indexed in Scilit:
- Anti-HLA Antibodies in Double Umbilical Cord Blood TransplantationTransplantation and Cellular Therapy, 2011
- Bortezomib in Kidney TransplantationJournal of Transplantation, 2010
- The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failureBlood, 2010
- Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 unitsBlood, 2009
- The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategyTransfusion, 2009
- Prospective Monitoring for Alloimmunization in Cord Blood Transplantation: “Virtual Crossmatch” can be Used to Demonstrate Donor-Directed AntibodiesTransplantation, 2009
- B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipientsBlood, 2009
- Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipientsBlood, 2006
- Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipientsBlood, 2006
- Clinical significance of recipient antibodies to stem cell donor mismatched class I HLA antigensHuman Immunology, 2004